Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.96	24.57	39.88	45.28	27.35
Short-Term Investments	70.79	89.02	79.23	172.29	164.07
Cash & Short-Term Investments	90.75	113.59	119.11	217.57	191.41
Cash Growth	-20.11%	-4.63%	-45.26%	13.66%	253.61%
Receivables	5.57	12.36	0.3	0.48	0.62
Prepaid Expenses	-	-	9.45	13.5	13
Total Current Assets	96.32	125.95	128.86	231.55	205.03
Property, Plant & Equipment	3.05	3.85	5.48	3.78	4.77
Long-Term Investments	60.61	90.3	62.77	12.24	34.24
Other Intangible Assets	-	-	-	6.97	7.05
Other Long-Term Assets	0.49	0.22	0.3	0.05	0.12
Total Assets	160.46	220.33	197.41	254.6	251.21
Accounts Payable	13.16	4.69	8.88	10.35	9.99
Accrued Expenses	7.41	7.76	10.86	8.2	7.37
Current Portion of Leases	0.55	0.48	0.43	0.68	0.72
Current Unearned Revenue	3.94	3.89	-	-	-
Other Current Liabilities	3.58	14.77	10.79	2.7	4.85
Total Current Liabilities	28.65	31.6	30.95	21.94	22.93
Long-Term Leases	1.57	2.12	3.07	1.57	2.17
Long-Term Unearned Revenue	16.17	20.04	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.37	0.37
Other Long-Term Liabilities	11	11.02	6.2	33.1	28.4
Total Liabilities	57.38	64.77	40.23	56.98	53.87
Common Stock	0	0	0	0	0
Additional Paid-In Capital	1,070	1,058	928.08	880.83	792.97
Retained Earnings	-967.78	-902.86	-770.8	-682.32	-595.41
Comprehensive Income & Other	0.61	0.1	-0.11	-0.9	-0.22
Shareholders' Equity	103.08	155.55	157.18	197.62	197.34
Total Liabilities & Equity	160.46	220.33	197.41	254.6	251.21
Total Debt	2.12	2.6	3.5	2.25	2.89
Net Cash (Debt)	149.25	201.3	178.38	227.56	222.76
Net Cash Growth	-25.86%	12.85%	-21.61%	2.15%	457.17%
Net Cash Per Share	1.22	2.60	2.56	3.49	3.93
Filing Date Shares Outstanding	120.6	107.92	70.93	66.69	61.28
Total Common Shares Outstanding	120.5	107.85	70.89	66.69	61.23
Working Capital	67.67	94.36	97.9	209.61	182.1
Book Value Per Share	0.86	1.44	2.22	2.96	3.22
Tangible Book Value	103.08	155.55	157.18	190.65	190.29
Tangible Book Value Per Share	0.86	1.44	2.22	2.86	3.11
Machinery	-	-	4.97	4.01	3.61
Leasehold Improvements	-	-	0.82	1.12	1.12

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q